ASML Shares Walk a Tightrope Between Bernstein’s Bullish Bet and Washington’s China Chill
Veröffentlicht: 09.07.2026 um 00:10 Uhr, Redaktion boerse-global.de
ASML’s stock is caught in a tug-of-war. On one side, a sweeping analyst upgrade from Bernstein points to explosive demand for the company’s cutting-edge chipmaking machines. On the other, the specter of stricter US export controls looms over its lucrative China business. The Dutch semiconductor-equipment maker’s shares currently trade at €1,558.40 in Frankfurt, up roughly 58% since the start of the year but still 10% below the 52-week high of €1,748 set on June 30.
Bernstein analyst David Dai has fired a warning shot across the consensus. He raised his price target on ASML by 33% to $2,623, well above the Wall Street average of $1,984. Dai maintains a buy rating, driven by a sharply higher forecast for the company’s EUV lithography systems — the essential tools for manufacturing the most advanced chips. Bernstein now expects 91 EUV units to be shipped in 2027, up from 86, and sees 113 units in 2028 versus a prior estimate of 87. By 2030, the EUV revenue stream should grow at a compound annual rate of 30% to reach €42.7 billion, more than 30% above current market expectations. The older DUV line gets an upgrade too: revenue is seen climbing from €13 billion in 2026 to €20 billion by 2030.
The bullish call fits into a broader analyst lovefest. Some 38 of 43 Wall Street analysts currently recommend buying ASML. Bernstein also raised price targets across the chip sector: TSMC to $430, Intel to $100, Micron to $1,300, and near-doubled targets for Samsung and SK Hynix. The reasoning is a clear timeline for the next chip generation: memory makers like SK Hynix and Samsung are expected to adopt ASML’s High-NA lithography in their DRAM production as early as 2027, with Intel following in 2028 for logic chips, Samsung in 2029, and TSMC in 2030.
Yet the rosy picture comes with caveats. Bernstein flags potential margin pressure from the costly commercialization of EUV technology, a larger-than-expected inventory buildup in China, and weaker demand for wafer-fabrication equipment. And the big unknown — further US export restrictions — could hit ASML’s China business hard. That exposure is already shrinking. Management had planned for China’s share of revenue to fall to 20% this year from 33% previously. But those numbers were set before the latest political push in Washington.
Should investors sell immediately? Or is it worth buying Asml?
The proposed MATCH Act, which aims to choke off China’s access to critical chip technologies, is causing real unease. ASML reported €8.8 billion in first-quarter 2026 revenue and €2.8 billion in net profit. For the full year, the company targets revenue between €36 billion and €40 billion with a gross margin near 52%. But the second quarter is expected to be weaker, and JPMorgan analysts warn that tighter controls could knock 10% off earnings.
Investors face two competing narratives. The optimists argue that insatiable AI demand will easily offset any regional losses. TSMC recently posted record revenue for the start of the year, confirming the robust health of the semiconductor market. If ASML’s order books for 2027 remain strong — especially as it delivers its new High-NA systems — the stock could reclaim its all-time high. Technically, the shares trade 6.5% above their 50-day moving average, a modest cushion.
The pessimists see a different outcome. With ASML no longer reporting quarterly order intake, the market must rely on delivery data. Any downward revision to the annual guidance because of China would trigger a severe reaction. The stock’s annualized volatility stands at 64%, meaning the rich valuation leaves no room for missteps. Dai himself acknowledges the risks but projects earnings per share of €67 in 2028 — 35% above the consensus — and €97 by 2030. Revenue could hit €80 billion by then, 24% above current estimates.
Asml at a turning point? This analysis reveals what investors need to know now.
The next big test comes in mid-July 2026, when ASML releases second-quarter results. Those numbers will determine which narrative wins. If management confirms its revenue and margin targets despite the political noise, the AI-fueled rally could extend. If it signals deeper cuts from new sanctions, the stock faces a brutal reality check. For now, ASML’s shares sit in a quiet consolidation zone, waiting for the next catalyst to tip the scales.
Ad
Asml Stock: New Analysis - 9 July
Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.
